Developing a precision LC-MS-based targeted metabolomics method for large-scale analysis of key metabolomes is likely to be of great value to investigations in the life sciences. Our new targeted-metabolomics method employs a reversed-phase liquid chromatography (RPLC) for non-polar metabolomes and hydrophilic interaction liquid chromatography (HILIC) for polar metabolomes with ultra-high performance liquid chromatography-triple-quadrupole mass spectrometry (UHPLC-TQ/MS) in a dynamic MRM scan-mode, we substantially increased the coverage to 240 metabolites of interest with largely variable polarity and improved detection capacity by fully optimizing analytical parameters with LC-and MS-units. This new method has the capacity to dynamically analyse the metabolome of interest in diverse biological matrixes by offering coverage of rat urine, plasma, liver, brain, intestine, stomach, heart, spleen, lung, faeces, fresh plant tissues, cells and microbes. In addition, this new method enables specific and efficient analysis of microdontia metabolomes, non-microdontia and whole cell metabolomes, as well as can engage in absolute determination of 84 key clinical-wide metabolites in different biological matrixes, to enable the complementary support of clinical diagnosis and classification of diseases. To demonstrate the applicable capacity of this new method, multiple-matrixes differential metabolomes were firstly characterized using this new method to coordinate metabolic modifications underlie hepatitis induced by carbon tetrachloride (CCL 4 ) in rats, such finding provides novel insight into the pathogenesis and therapeutics of hepatitis in clinic. Altogether, we are fully confident that this new metabolomics method will be widely welcomed by scientists in different niches to solve their key questions accordingly.
Metabolism is characterized by a series of essential life-sustaining processes in all organisms through which living cells acquire necessary nutrients and energy, which enables cells to grow, differentiate and function. By characterizing the altered metabolism underlying diverse biochemical events and/or processes, we could solve key problems in different niches, such as biomedicine, bioengineering, agriculture and the environment [1] [2] [3] . In the late 1990s, a systems biology-driven metabolomics method was first proposed to provide a comprehensive approach to precisely investigate metabolism 4, 5 via global and quantitative analyses of endogenous metabolites in biological systems that require data acquired through high-resolution analytical technologies 6 .
To the best of our knowledge, untargeted metabolomics is seriously limited to the identification of differential metabolites for which reference compounds are unavailable and often provides only the metabolic phenotypes 7, 8 , such that no functional experiments can be completed without the purified compounds of interest.
In contrast, obtaining reference compounds is facilitated by targeted metabolomics and is becoming a prevalent methodology for studying functional metabolism, owing to the commercial availability of the differential compounds, and further functional studies on regulatory genes and biosynthetic enzymes can help precisely determine the biochemical mechanisms underlies the altered metabolism 9, 10 . Developing a high-throughput LC-MS-based targeted metabolomics method for large-scale analysis of known metabolomes is likely to be of great value to investigations in the life sciences 11, 12, 13 .
With this new-developed metabolomics method, referring to our prior publication in JPR in 2011 13 , we were the first to optimally select and retrieve 240 small-molecule metabolites with important biological functions featured broadly in key publications (Figure 1) , including organic acids, fatty acids, sugars, phosphate-sugars, amino acids and lipids, that are closely associated with disease progression, pathogenesis and therapeutic discovery [13] [14] [15] [16] . Then, UHPLC-TQ/MS parameters was fully optimized to enable reversed-phase liquid chromatography (RPLC) for non-polar metabolomes assay and hydrophilic interaction liquid chromatography (HILIC) for polar metabolomes assay ( Figure 2 ) in a dynamic MRM scan-mode (Table S1 ). This new method has the capacity to significantly enhance the detectable levels of the metabolites of interest and widens the coverage to include their polarity [17] [18] (Figure 3) .
To tailor the translational applicability of this method for use in the full-spectrum of life sciences, we sought to analyse the metabolomes of interest present in a range of diverse biological matrixes (Figure 4 ). It is exciting to illustrate the collective data that this protocol has been able to obtain efficiently for targeted characterization of metabolomes from rat urine, plasma, liver, brain, intestine, stomach, heart, spleen, lung and faeces; fresh plant tissues; cells; and microbes ( Figure 5A and C) .
Importantly, in terms of microdontia, it is quite important to understand the related cell metabolism, because metabolic dysregulation is implicated in numerous important biological processes and events, such as cancers, diabetes, and immunological deficiency, and the whole cell-metabolome assay often cannot be used for precise characterization of the functional features of dysregulated microdontia related to different biological events. To improve this assay, our new protocol was developed to enable the simultaneous analysis of microdontia metabolomes, non-microdontia metabolomes, and whole-cell metabolomes ( Figure 5B ). When making a comparison among cancer cell lines, microdontia metabolomes are much better than non-microdontia metabolomes or whole-cell metabolomes for investigating metabolic reprogramming during cancer progression. Finally, for improved clinical diagnosis and classification of targeted diseases, we also determined calibration curves for precise quantification of metabolite biomarkers, and 84 key metabolites were eventually and absolutely quantified in both plasma and urine samples, as well as other tissue matrixes (Tables 2 and 3) . Collectively, the rapid determination of these 84 key metabolites with our targeted metabolomics protocol has great potential for use in complementing the clinical diagnosis of complex diseases ( Figure 6 ). To demonstrate the applicable capacity of this new method, multiple-matrixes differential metabolomes were firstly characterized using this new method to coordinate metabolic modifications underlie hepatitis induced by carbon tetrachloride (CCL 4 ) in rats. Such findings verify the robustness and applicable potential of this new targeted metabolomics method, as well as provide novel insight into the pathogenesis and therapeutics of hepatitis in clinic from multisensorial metabolic perspective (Figure 7) .
Taking all these advantages together, this novel protocol for targeted metabolome assays has substantial coverage of 240 key metabolites in dozens of important metabolic pathways. This method can enable the use of metabolome assays with different biological matrixes and offers a new horizon for analyses of microdontia metabolomes, non-microdontia metabolomes, and whole-cell metabolomes.
In short, this new method is far better than previous protocols of targeted metabolome assays, particularly in terms of matrix adaptation, capacity for absolute quantification, and new and future applications for the analysis of microdontia metabolomes and non-microdontia metabolomes. We are fully confident that this protocol will be widely welcomed by scientists studying different biological niches to solve their key questions accordingly (Figure 8 ).
Materials and Methods

Chemicals and reagents
All of reference compounds for targeted metabolomes of interest ( Table 1) were purchased from Sigma-Aldrich Corp (Saint Louis, USA), and 1 mg/mL stock solution was prepared by dissolving them into water or methanol, respectively.
Methanol, acetonitrile and formic acid (HPLC-grade) were purchased from Thermo Fisher Scientific (Shanghai, China). Ammonium acetate (HPLC grade) was purchased from Merck KGaA (Darmstadt, Germany). LB broth (Luria−Bertani) and LB agar were purchased from Becton Dickinson (Sparks, USA). Magnesium sulfate, manganese chloride, casamino acid, yeast extract, of USP grade, were purchased from Sigma-Aldrich Corp (Saint Louis, USA). The distilled water was purchased from A.S. Watson Group (Guangzhou, China). All other reagents were of ACS grade.
UPLC/TQ MS system
An UPLC system (1290 Infinity series, Agilent Technologies) coupled to a triple quadrupole mass spectrometer (Agilent 6495, Agilent Technologies) was used for precision-targeted metabolome assay in a dynamic MRM mode (DMRM). The optimized dynamic MRM parameters for the targeted metabolomes were listed in Medicine. All efforts were made to ameliorate the suffering of the animals.
Bacterial strains and cultivation
The UTI89 and MG1655 strains were firstly cultured in LB-agar plate for 12 h, then one colony was collected to incubated with LB broth medium for 4 h, diluted 1000-fold into CFA medium and further cultivated for 72 h at 30°C to trigger mature biofilm formation. CFA medium is consisted of 1% Casamino acids, 0.15% yeast extract, 0.005% magnesium sulfate and 0.0005% manganese chloride.
Isolation of mitochondria from cells
Cell line Panc-1 was purchased from the American Type Culture Collection (ATCC)， the cells are cultured in DMEM medium supplied with 10% fetal bovine serum and 1%
Penicillin-Streptomycin, maintained at 37°C in a humidified atmosphere containing 5% CO 2 . In order to obtain a significant quantity of mitochondria, an appropriate number at about 3 million cells were seeded in a 150 mm dish and grown to approximately 2 × 10 7 cells. The isolated mitochondria and cytosolic fraction were achieved by commercially available mitochondria isolation kit (Beyotime, China). The isolation was performed according to a modified manufacturer's protocol. Briefly, cells were washed with ice cold PBS, followed by adding 1 mL of the prepared 1×Extraction
Buffer A, then incubated on ice for 10 minutes. To further homogenize the cells on ice with a dounce homogenizer for 15 strokes. The extraction was centrifuged under 600 × g for 10 minutes at 4 °C, and carefully transfer the supernatant into a new PE tube, centrifuge under 11,000 × g for 10 minutes at 4 °C. At last, the supernatant was collected as cytosolic fraction and the pellets were mitochondria. All the isolation process should be performed on ice.
Metabolome extraction
Body fluids Referring to our previous protocol 13 , we made a revised version as below, briefly, the urine samples could be directly analyzed with LC-TQ MS after a simple preparation as urinary samples were centrifuged under 20,000 g at 4 o C for 10 min and filtered by 0.22 µm Millipore filter. 100 uL of plasma samples were mixed with 4 volume of iced-cold acetonitrile to precipitate proteins, then centrifuged to 20,000 g for 10 min at 4 o C. Following the supernatant was transferred to a new 1.5-mL microcentrifuge tube and dried with N 2 , finally dissolved in 100 µl of water and centrifuged again before analyzed by LC-TQ MS.
Tissues Brain, heart, liver, spleen, kidney, small intestine and lung share the same protocol for metabolome extraction. About 100-130 mg tissue samples were weighed and placed into a 2-mL screw-cap plastic microvials containing about 1 g glass beads (1.0 mm i.d.). Then tissues were completely homogenized at a 2-min run for 3 times (after one run we need to put the sample on ice for cooling) in 1.2 ml of 80% ice-cold methanol by Mini-Beadbeater-16 (Biospec Products). After that, spun down at 20,000 g for 10 min and vortexed with 800 µl of iced-cold acetonitrile, centrifuged again to remove the protein precipitates. The supernatant was processed following the same procedure as plasma samples. Quality control (QC) samples by pooling aliquots of all samples were analyzed during the whole LC-TQ MS analysis.
Bacterial strains Referring to the previous protocol 14 , we made a revised version.
Firstly, biofilm samples were isolated from 50 mL of culture solution, to obtain the planktonic cells, the supernatants in the culture medium were centrifuged to 931 g at 4 o C for 15 min. After wash the biofilm with 2 mL PBS for 3 times, add 2 mL of 80% ice-cold methanol, homogenize by homogenizer for 2 minutes, 3 times. All procedures were performed on ice for cooling. Then, the homogenate was spun down at 13201 g to collect the supernatants. After adding 800 µL of ice-cold acetonitrile, centrifuged again, the fresh supernatants were filtered through 0.22µm filter membrane and stored in -80℃before lyophilization. The lyophilized samples were dissolved in 100 µL of water and centrifuged again before analyzed with LC-TQ MS.
Cells, cytoplasm and mitochondrial metabolome extraction of the isolated mitochondrial was done by following the same procedure as that of tissue samples except for replacing the 1.0 mm i.d. of glass beads with 0.5 mm. The cytoplasm samples were mixed with 800 µL iced-cold acetonitrile to precipitate proteins, then following the steps of plasma-metabolome preparation. For whole cells, firstly, wash cells twice with PBS, following add 1.2 mL 80% ice cold aqueous methanol and all the cells were harvested by cell scraper on ice, and transferred to a 2-mL screw-cap plastic micro-vial, then homogenized, centrifuged; at last, adding iced-cold acetonitrile and following the routine procedure as the metabolome extraction of bacterial cells.
Absolute determination of key clinical-wide metabolites
To assist clinical diagnosis of a variety of diseases with this new developed metabolomics method, we adopted a set of external standards by containing at least five-levels concentration to establish the calibration curve. 84 key clinical-wide metabolites can be absolutely determined by the developed precision-targeted metabolomics method (Table S2 ). In this case, we attempt to verify the efficiency of this new developed method by selectively determining the absolute concentration of 27 key metabolites present in a diverse biological-matrixes (Table S3 ).
Data Processing and Statistical Analysis
The MS raw data generated from the biological samples was firstly processed by qualitative Analysis, with an in-house software of Agilent Corps, which integrated the signal-peaks and generated a three-dimension data-matrixes with peak-area of merabolite-metabolite ID-sample ID. After peak area for each metabolite was normalized to tissue weight of each sample, the processed data was uploaded onto free MetaboAnalyst online-softare (http://www.metaboanalyst.ca/MetaboAnalyst/)
for partial least-squares discriminant analysis (PLS-DA) and heatmap vs hierarchical-cluster analysis (HCA). 
Figure Legends
